Zobrazeno 1 - 10
of 229
pro vyhledávání: '"Hermann Josef Gertz"'
Autor:
Martin Berwig, Stephanie Heinrich, Jenny Spahlholz, Nina Hallensleben, Elmar Brähler, Hermann-Josef Gertz
Publikováno v:
BMC Geriatrics, Vol 17, Iss 1, Pp 1-13 (2017)
Abstract Background Individualized, outreach and structured multicomponent interventions are a promising intervention approach to relieve the burden of informal caregivers of people with dementia. In this study, we adapted and evaluated a multicompon
Externí odkaz:
https://doaj.org/article/2afa03ca86094d8ab821748e5887044e
Autor:
Henryk Barthel, Jörg Steinbach, Steffen Fischer, René Smits, Diego Cecchin, Osama Sabri, Bernhard Sattler, Marianne Patt, Solveig Tiepolt, Julia Luthardt, Georg-Alexander Becker, Alexander Hoepping, Gudrun Wagenknecht, Hermann-Josef Gertz, Michael Rullmann, Friedrich-Alexander Ludwig, Winnie Deuther-Conrad, Peter Brust, S Wilke, Philipp Meyer, Swen Hesse
Publikováno v:
European journal of nuclear medicine and molecular imaging 48(3), 731-746 (2021). doi:10.1007/s00259-020-05029-w
European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging
Purposes We present the first in-human brain PET imaging data of the new α4β2 nicotinic acetylcholine receptor (nAChR)–targeting radioligand (+)-[18F]Flubatine. Aims were to develop a kinetic modeling-based approach to quantify (+)-[18F]Flubatine
Autor:
Anil Batra, Thomas Dresler, Stephan Fuchs, Hermann-Josef Gertz, Winfried Häuser, Frank Petzke, Adrian Rosada, Clemens Veltrup, Ursula Havemann-Reinecke
Publikováno v:
S3-Leitlinie Medikamentenbezogene Störungen ISBN: 9783662638415
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81e5421cc52607096d8c11e843200a9c
https://doi.org/10.1007/978-3-662-63842-2_1
https://doi.org/10.1007/978-3-662-63842-2_1
Memory concerns, memory performance and risk of dementia in patients with mild cognitive impairment.
Autor:
Steffen Wolfsgruber, Michael Wagner, Klaus Schmidtke, Lutz Frölich, Alexander Kurz, Stefanie Schulz, Harald Hampel, Isabella Heuser, Oliver Peters, Friedel M Reischies, Holger Jahn, Christian Luckhaus, Michael Hüll, Hermann-Josef Gertz, Johannes Schröder, Johannes Pantel, Otto Rienhoff, Eckart Rüther, Fritz Henn, Jens Wiltfang, Wolfgang Maier, Johannes Kornhuber, Frank Jessen
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e100812 (2014)
Concerns about worsening memory ("memory concerns"; MC) and impairment in memory performance are both predictors of Alzheimer's dementia (AD). The relationship of both in dementia prediction at the pre-dementia disease stage, however, is not well exp
Externí odkaz:
https://doaj.org/article/e75eda8c03cc4d10b0092a249e536352
Autor:
Hermann-Josef Gertz
Publikováno v:
Praxishandbuch Gerontopsychiatrie und-Psychotherapie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2b6f9bdd02ff63b88afce63dd007133
https://doi.org/10.1016/b978-3-437-24436-0.00007-4
https://doi.org/10.1016/b978-3-437-24436-0.00007-4
Autor:
Frank M. Schmidt, Juergen Kratzsch, Hermann-Josef Gertz, Mandy Tittmann, Ina Jahn, Uta-Carolin Pietsch, Udo X. Kaisers, Joachim Thiery, Ulrich Hegerl, Peter Schönknecht
Publikováno v:
PLoS ONE, Vol 8, Iss 6 (2013)
Externí odkaz:
https://doaj.org/article/6b24f9773e324dfe966117cd757c5508
Autor:
Frank M Schmidt, Juergen Kratzsch, Hermann-Josef Gertz, Mandy Tittmann, Ina Jahn, Uta-Carolin Pietsch, Udo X Kaisers, Joachim Thiery, Ulrich Hegerl, Peter Schönknecht
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e63136 (2013)
Ancillary to decline in cognitive abilities, patients with Alzheimer's disease (AD) frequently suffer from behavioural and psychological symptoms of dementia (BPSD). Hypothalamic polypeptides such as melanin-concentrating hormone (MCH) and hypocretin
Externí odkaz:
https://doaj.org/article/14fb589487a2466bb1977a6c957e0d79
Autor:
Osama Sabri, Philipp M. Meyer, Hermann-Josef Gertz, Solveig Tiepolt, Peter Brust, Henryk Barthel, Swen Hesse
Publikováno v:
PET and SPECT in Neurology ISBN: 9783030531676
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::507c05096db591f0ac91d1c59449498e
https://doi.org/10.1007/978-3-030-53168-3_11
https://doi.org/10.1007/978-3-030-53168-3_11
Autor:
Matthias L. Schroeter, Karl-Titus Hoffmann, Thies H. Jochimsen, Dorothee Saur, Julia Luthardt, Jörg Berrouschot, Bernhard Sattler, Osama Sabri, Joseph Classen, Lisa Florek, Marianne Patt, Hermann-Josef Gertz, Arno Villringer, Solveig Tiepolt, Swen Hesse, Henryk Barthel
Publikováno v:
Journal of Alzheimer's Disease. 66:1105-1116
BACKGROUND Current research diagnostic criteria for Alzheimer's disease (AD) and mild cognitive impairment (MCI) due to AD include biomarkers to supplement clinical testing. Recently, we demonstrated that dual time-point [18F]FBB PET is able to deliv
Autor:
John Seibyl, Hiroyasu Akatsu, Aleksandar Jovalekic, Danielle Richards, Oliver Peters, Keshav Anand, Marwan N. Sabbagh, Christopher C. Rowe, Barbara Schäuble, Walter J. Schulz-Schaeffer, Henryk Barthel, Masaki Takao, Natalie L. Rasgon, Colin L. Masters, Hermann-Josef Gertz, Osama Sabri, Shigeo Murayama
Publikováno v:
Journal of Alzheimer's Disease. 56:441-446
Of 57 individuals diagnosed with Alzheimer's disease (AD) in a phase III study, 13 (23%) had amyloid-β (Aβ) levels on postmortem histopathology that did not explain the dementia. Based on postmortem histopathology, a wide range of different non-AD